Risk of recurrent stroke for Asian stroke patients treated with non-vitamin K antagonist oral anticoagulant and warfarin.

Ther Adv Chronic Dis · 2020 · PMC7705193 · PMID 33294148

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an unfavorable trendno p-value reported

An earlier randomized clinical trial (RCT) comparing edoxaban and warfarin showed an unfavorable trend for low-dose edoxaban to prevent systemic embolism and stroke. 14 However, a recent published RCT for elderly Asian patients with AF favored low-dose edoxaban to prevent systemic embolism and stroke. 26 The optimal dose for Asian patients using edoxaban needs to be determined by further studies.

also in 104 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.